Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention ACC/AHA guidelines for beta blockers


 * Associate Editors-in-Chief: Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

==ACC / AHA Guidelines - Beta Blockers(DO NOT EDIT) ==

{{cquote|

Class I
1. Beta blockers are indicated for all patients recovering from UA / NSTEMIunless contraindicated. Treatment should begin within a few days of the event, if not initiated acutely, and should be continued indefinitely. (Level of Evidence: B)

2. Patients recovering from UA / NSTEMI with moderate or severe LV failureshould receive beta blocker therapy with a gradual titration scheme. (Level of Evidence: B)

Class IIa
1. It is reasonable to prescribe beta blockers to low-risk patients (i.e., normal LV function, revascularized, no high risk features) recovering from UA / NSTEMI in the absence of absolute contraindications. (Level of Evidence: B)}}